Hallura Competitors and Similar CompaniesClear all
Hallura's competitors and similar companies include Trauer, Evofem Biosciences, Revance Therapeutics and Anika Therapeutics.
 Hallura Hallura is an aesthetic medical company developing a new generation of hyaluronic acid (HA) dermal fillers. |  Trauer Guangzhou Trauer Biotechnology (广州创尔生物技术股份有限公司) is a biomedical research and development company. |  Evofem Biosciences Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products. |  Revance Therapeutics Revance Therapeutics is a biotechnology company that develops and commercializes aesthetic and therapeutic offerings. |  Anika Therapeutics Anika Therapeutics develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair. | |
Founding Date | Founding Date 2017 | Founding Date 2002 | Founding Date 2007 | Founding Date 2002 | Founding Date 1992 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Yokne'am Illit, IL HQ | Locations Guangzhou, CN HQ | Locations San Diego, US HQ | Locations Nashville, US HQ Irvine, US Newark, US Pleasanton, US | Locations Bedford, US HQ Padova, IT Padova, IT Franklin, US |
Employees | Employees 215% increase | Employees 3289% decrease | Employees 3030% increase | Employees 59712% increase | Employees 15416% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.2 m | Valuation ($) 615.7 m | Valuation ($) 365 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥390.8m (FY, 2025) | Revenue (est.) $20.2m (FY, 2025) | Revenue (est.) $234m (FY, 2023) | Revenue (est.) $112.8m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥99.3m (FY, 2025) | Cost of goods $4.6m (FY, 2025) | Cost of goods $74.4m (FY, 2023) | Cost of goods $49m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥292.5m (FY, 2025) | Gross profit $15.6m (FY, 2025) | Gross profit $159.7m (FY, 2023) | Gross profit $63.8m (FY, 2025) |
Net income | Net income N/A | Net income ¥29m (FY, 2025) | Net income $391k (FY, 2025) | Net income ($324m) (FY, 2023) | Net income ($10.9m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Trauer
HQ
Guangzhou, CN
Employees
328↓ 9% decrease
Guangzhou Trauer Biotechnology (广州创尔生物技术股份有限公司) is a biomedical research and development company.
View companyEvofem Biosciences
HQ
San Diego, US
Employees
30↑ 30% increase
Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products.
View companyRevance Therapeutics
HQ
Nashville, US
Employees
597↑ 12% increase
Revance Therapeutics is a biotechnology company that develops and commercializes aesthetic and therapeutic offerings.
View companyAnika Therapeutics
HQ
Bedford, US
Employees
154↑ 16% increase
Anika Therapeutics develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair.
View company